EV
Eric Venker sold $7.3M of ROIV stock
Eric Venker, President & Immunovant CEO of Roivant Sciences Ltd. (ROIV), sold 200,000 shares of ROIV stock worth $7.3M, per an SEC Form 4 filed Oct 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 28, 2026, 2 days before it was made public.
ROIV has moved +4.2% since the trade date, from $37.11 to $38.66 (Nov 20, 2026 close).
- Traded
- Oct 28, 2026
- Disclosed
- Oct 30, 2026
- Filing delay
- 2 days
- Price since
- +4.2%
- Role
- President & Immunovant CEO
- Source
- SEC Form 4